Lyell Immunopharma Inc (LYEL) Unusual Options Activity Today

Checking LYEL unusual options activity helps you spot when traders are making outsized bets on Lyell Immunopharma Inc before the broader market catches on. Lyell Immunopharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor LYEL unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching LYEL unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking LYEL unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and LYEL unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications.

The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Catalysts rarely arrive without a footprint, and LYEL unusual options activity is often where that footprint shows up first. Our scanner tracks Lyell Immunopharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at LYEL unusual options volume on the call side or chasing put sweeps, Lyell Immunopharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.